Technical Due Diligence - Biotech

I don't see many biotech / pharma posts on these forums, but based on answers to other posts I thought this might be a good place for this question.

Is there a market for technical due diligence in biotech investment? In other words, would angels / VC be interested in the services of a technical due diligence group to obtain a 3rd party expert perspective on potential biotech technologies?

It seems like this would alleviate some burden from the investors, and aid in the assessment of a broad spectrum of technologies.

I ask because I am fairly well-positioned to recruit a high-quality consulting group and have had this thought in the back of my mind for the past year or so.